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Abstract
Background: As the incidence of  HIV infection has increased its neurological complications are being encountered in our 
clinical practice. Toxoplasmosis is a common cerebral opportunistic infection seen in HIV-infected patients, even though the 
incidence has declined with the use of  antiretroviral therapy. Establishing a definitive diagnosis of  cerebral toxoplasmosis is 
difficult in resource limited settings. 
Clinical case: A 20 year old gentleman was referred to our institute as a case of  stroke. Magnetic resonance imaging (MRI) 
of  his brain showed multiple ill-defined and nodular enhancing lesions in bilateral supratentorial and infratentorial neuropa-
renchyma. Test for HIV-1 was reactive. Toxoplasma serology revealed raised IgG antibody levels. Based on the MRI features 
and positive toxoplasma serology a diagnosis of  cerebral toxoplasmosis was made. He was treated with trimethoprim/
sulfamethoxazole and pyrimethamine/ Sulfadoxine for 3 weeks. After 2 weeks of  treatment, repeat MRI of  brain was done 
which showed significant resolution of  the lesions. 
Conclusion: We are presenting this case to highlight the fact that cerebral toxoplasmosis should be considered in the differ-
ential diagnosis of  multiple neuroparenchymal lesions in young individuals who present with neurological deficits.
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Introduction
Toxoplasmosis, Tuberculosis, cryptococcosis, CNS 
lymphoma and progressive multifocal leukoencepha-
lopathy affect the central nervous system in HIV-infect-
ed patients. An accurate diagnosis of  these neurological 
complications is crucial because effective intervention 
will lead to longer survival .
Toxoplasmosis occurs in patients with CD4 T cell 
counts below 200 cells/μL. Like most CNS diseases in 
HIV, establishing a definitive diagnosis of  Toxoplasmo-
sis is often difficult in resource limited settings thereby 
requiring a therapeutic trial1. In routine clinical practice 
treatment is usually initiated based on radiological fea-
tures and serology.We present a case of  CNS toxoplas-
mosis in a 20 year old male.
Case Report
A 20-year-old male was referred to our institution as a 
case of  stroke . He had suffered from mild headache for 
two weeks. One day prior to admission he developed 
confusion and right sided hemiparesis. He was treated 
for pulmonary tuberculosis 1 year ago. On examination 
he was confused and had right hemiparesis.
Lab investigations showed haemoglobin -10.8 g/dl, to-
tal White Blood Cell count -5600 cells/cu.mm, Neutro-
phil- 86%, Lymphocyte- 4%,eosinophil-6%,Monocyte- 
4%, platelet count-2,02,000 cells/cu.mm, ESR- 90mm. 
Serum electrolytes, blood sugar, renal and liver func-
tion tests were normal. Test for HIV-1 was reactive. His 
CD4T cell count was 22cells/μL. Chest X-ray and ultra-
sound of  the abdomen were normal.
MRI brain (Figure 1) showed multiple ill-defined and 
nodular enhancing lesions in bilateral supratentorial and 
infratentorial neuroparenchyma. Involvement of  bilat-
eral basal ganglia, thalamus and brainstem was noted. 
Gram stain, Ziehl Neelsen stain, India ink stain and cul-
ture of  CSF were negative.
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Toxoplasmosis serology revealed raised IgG antibody 
levels of  325 IU/ml.
He was treated with mannitol, trimethoprim (160mg)/
sulfamethoxazole (800mg) thrice daily, pyrimethamine 
(25mg)/sulfadoxine (500mg) thrice daily ,folinic acid 
and anticonvulsants. His symptoms such as confusion, 
headache improved gradually within one week of  ad-
mission. After two weeks repeat MRI of  brain was 
done which showed significant resolution of  the lesions 
(Figure 2). 
Coronal T1weighted post contrast image showing supratentorial and infratentorial ring 







Repeat MRI of brain after 2 weeks showing significant resolution of the lesions. 
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He was treated for three weeks. Antiretroviral drugs were 
started (Tenofovir (300mg), Emtricitabine (200mg) and 
Efavirenz (600mg) once daily. Patient was discharged 
from hospital in an ambulatory state. He was advised 
to continue antiretroviral drugs, anticonvulsants and 
trimethoprim/sulfamethoxazole (prophylaxis) .He has 
been on regular follow up for the past thirty months.
 
Discussion
Neurologic manifestations are frequent in patients with 
human immunodeficiency virus (HIV) infection.
Toxoplasmosis is caused by Toxoplasma gondii. Cats 
are definitive hosts. They excrete parasite’s oocysts in 
their faeces. Transmission occurs due to ingestion of  
either oocysts from contaminated soil, food or water 
or from undercooked meat. The major clinical features 
of  cerebral toxoplasmosis are headache, fever, altered 
sensorium ,seizures and focal neurological defecits2
 
The classical radiological pictures of  Toxoplasmosis are 
multiple parenchymal lesions, with ring enhancement, 
which are generally localized at the corticomedullary 
junction or basal ganglia. On MRI these lesions appear 
hypointense on T1 weighted images with up to 70% 
showing ring enhancement with contrast3. Toxoplas-
mosis may just present with hydrocephalus in the ab-
sence of  parenchymal lesions4. Cerebral toxoplasmosis 
and primary cerebral lymphoma are the common caus-
es of  ring enhancing lesions of  central nervous system 
in patients with AIDS. However, it is often difficult to 
distinguish between these two conditions clinically and 
radiographically5.
 
Neurocysticercosis must be included in the differential 
diagnosis of  neurologic infections in HIV patients in 
endemic populations6. Other  conditions that can cause 
ring enhancing lesions are tuberculomas, gliomas, me-
tastases and abscesses7.    
The definitive diagnostic procedure is brain biopsy8. 
Brain biopsy should only be considered in patients 
with negative toxoplasmosis serology and who do not 
respond to treatment9. Negative serology for antitoxo-
plasma IgG antibodies should prompt the clinician to 
consider an alternative diagnosis10. Molecular diagnosis 
(conventional PCR and other types of  PCR) is also an 
important tool  to detect toxoplasmosis11,12.These new 
tools are not easily available for clinicians in developing 
countries.
Pyrimethamine (200-mg oral loading dose, followed by 
50–75 mg/day orally) sulfadiazine (1500 mg 4 times 
daily) or Trimethoprim (5 mg/kg) /sulfamethoxazole 
(25 mg/kg) twice daily are the drugs that are used to 
treat toxoplasmosis10. In our centre, we use trimethop-
rim/sulfamethoxazole and pyrimethamine /sulfadox-
ine to treat AIDS- associated cerebral toxoplasmosis as 
sulfadiazine is not available in our state. Trimethoprim/
sulfamethoxazole is an alternative treatment for tox-
oplasma encephalitis because it is inexpensive and as 
effective as pyrimethamine-sulfadiazine13. In toxoplas-
mosis radiological improvement is seen in most of  the 
patients after two to three weeks of  treatment14. MRI 
brain was repeated in our patient after 2 weeks which 
showed resolution of  the lesions.At least three weeks 
of  treatment is needed for toxoplasmosis.
 
Our patient presented with altered sensorium , hemip-
aresis and MRI brain revealed multiple lesions in bilat-
eral supratentorial and infratentorial neuroparenchyma. 
Early empirical antitoxoplasmosis treatment based on 
MRI was started and the patient improved.
 
Conclusion
Cerebral toxoplasmosis should be considered in the 
differential diagnosis of  multiple neuroparenchymal 
lesions in individuals who present with neurological 
deficits. Once cerebral toxoplasmosis is suspected, 
treatment should be started empirically pending the 
confirmation of  the diagnosis. Imaging studies of  the 
brain along with serology play an important role in the 
diagnosis of  toxoplasmosis. 
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